The true story of the Samoa measles outbreak
Who is at fault?
Related Articles
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
PURPOSEIn patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), brentuximab vedotin (BV) as monotherapy or combined with either lenalidomide (Len) or rituximab…
T cell malignancies after CAR T cell therapy in the DESCAR-T registry
Nature Medicine – This analysis of the registry database DESCAR-T of more than 3,000 pediatric and adult patients with hematological malignancies who received CAR T cell…
AI in medicine: preparing for the future while preserving what matters
2025 is here and medicine has continued to move away from the utopian vision of our admission essays for medical school. We are spending countless…
Program Guide – ASCO Meeting Program Guide
Presenter: Elizabeth Nally, BSc, MBBS Presenter: Atulya Aman Khosla, MD, MBBS Presenter: Annalis a Guida, MD Presenter: Alan Pollack, MD, PhD Presenter: Sean Ryan Miller,…
As academic Bluesky grows, researchers find strengths—and shortcomings
Platform fosters collegial interactions among scientists, but potentially limits interactions beyond the academic community
Hyper‐CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome‐Negative B‐Cell Acute Lymphoblastic Leukemia
Adding inotuzumab ozogamicin (InO) to hyper-CVAD and blinatumomab may improve outcomes in newly diagnosed Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (B-ALL). Patients w…
A conversation with Margaret McCartney, MD, PhD regarding evidence-based medicine and conflicts of interest
Listen now | A conversation with Margaret McCartney
Pre-treatment Pulmonary Function Testing Has Limited Utility In B-cell Lymphoma Treated with CD19 CAR T-cells
Key Points. No significant association was identified between PFT metrics and CRS grade >2 or ICANS grade >2Lack of correlation between PFT metrics a
Medicare’s $2,000 prescription drug cap expected to bring major relief to cancer patients
The new price cap, part of the Inflation Reduction Act, will apply to all prescription drugs covered by Medicare.
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy shows promising efficacy and manageable toxicity and could be a potential treatment option for patients with brain…
